Effect of Hydroxyapatite Nanoparticles on Ibuprofen Release from Carboxymethyl-Hexanoyl Chitosan/O-Hexanoyl Chitosan Hydrogel

2006 ◽  
Vol 6 (9) ◽  
pp. 2929-2935 ◽  
Author(s):  
Tse-Ying Liu ◽  
Ting-Yu Liu ◽  
San-Yuan Chen ◽  
Shian-Chuan Chen ◽  
Dean-Mo Liu
Keyword(s):  
Drug Release ◽  
Release Kinetics ◽  
Burst Release ◽  
Release Behavior ◽  
Chitosan Hydrogel ◽  
Sequential Release ◽  
Water Accessibility ◽  
Hydrophilic Nature ◽  
Hexanoyl Chitosan ◽  
Kinetics Of

In order to explore the effect of nanofiller on the regulation of the drug release behavior from microsphere-embedded hydrogel prepared by carboxymethyl-hexanoyl chitosan (HNOCC) and O-hexanoyl chitosan (OHC), the release kinetics was investigated in terms of various amounts of calcium-deficient hydroxyapatite (CDHA) nanoparticles incorporated. HNOCC is a novel chitosan-based hydrophilic matrix with a burst release profile in a highly swollen state. The drug release kinetics of the HNOCC hydrogel can be regulated by incorporation of well-dispersed CDHA nanoparticles. It was found that the release duration of ibuprofen (IBU) from HNOCC was prolonged with increasing amounts of CDHA which acts as a crosslink agent and diffusion barrier. On the contrary, the release duration of the IBU from OHC (hydrophobic phase) was shortened through increasing the CDHA amount over 5%, which is due to the hydrophilic nature of the CDHA nanoparticles destroying the intermolecular hydrophobic interaction and accelerating OHC degradation. Thus, water accessibility and molecular relaxation were enhanced, resulting in a higher release rate. In addition, sustained and sequential release behavior was achieved by embedding the OHC microspheres (hydrophobic phase) into the HNOCC (hydrophilic phase) matrix, which could significantly prolong the release duration of the HNOCC drug-loaded implant.

scholarly journals Stimuli-responsive DOX release behavior of cross-linked poly(acrylic acid) nanoparticles

e-Polymers ◽  
2019 ◽  
Vol 19 (1) ◽  
pp. 203-214 ◽  
Author(s):  
Goolia Nikravan ◽  
Vahid Haddadi-Asl ◽  
Mehdi Salami-Kalajahi
Keyword(s):  
Drug Release ◽  
Acrylic Acid ◽  
Cancer Drug ◽  
Cross Linking ◽  
Burst Release ◽  
Release Behavior ◽  
Molar Ratios ◽  
Distillation Precipitation Polymerization ◽  
Kinetics Of ◽  
Poly Acrylic Acid

AbstractCross-linked poly(acrylic acid) nanoparticles were synthesized via distillation precipitation polymerization of acrylic acid and ethylene glycol dimethacrylate withdifferent molar ratios. Spherical nanoparticles with diameters between 75 and 122 nm were synthesized and exhibited temperature and pH-responsive behaviors. However, this behavior was less pronounced for samples with higher cross-linking degrees. The potential of all nanoparticles as carriers for controlled release of doxorubicin (DOX) anti-cancer drug was examined at pH values of 1.2, 5.3 and 7.4. An obvious alleviation in burst release behavior and the amount of cumulative drug release was seen for all nanoparticles as the pH of the medium and the cross-linking degree of nanoparticle increased. Also kinetics of drug release was studied using mathematical models of zero-order, first-order, Higuchi, Korsmeyer-Peppas and Hixson-Crowell, where Higuchi and Korsmeyer-Peppas models best defined the kinetics of drug release.

scholarly journals Gelatin Beads/Hemp Hurd as pH Sensitive Devices for Delivery of Eugenol as Green Pesticide

2021 ◽  
Author(s):  
Gianluca Viscusi ◽  
Giuliana Gorrasi
Keyword(s):  
Release Kinetics ◽  
Barrier Properties ◽  
Ph Sensitive ◽  
Release Behavior ◽  
Sorption Coefficient ◽  
Highly Sensitive ◽  
Mean Diameter ◽  
Ph Conditions ◽  
Kinetics Of ◽  
Hemp Hurd

AbstractIn this paper gelatin beads reinforced with natural hemp hurd have been produced as pH sensitive devices for the release of eugenol, as green pesticide. The composites beads, with a mean diameter of about 1 mm, were obtained by polymer droplet gelation in sunflower oil. Thermal properties were evaluated showing no noticeable difference after the introduction of hemp hurd. Barrier properties demonstrated an improvement of hydrophobization. The introduction of 5% w/w of hemp hurd led to a reduction of sorption coefficient of about 85% compared to unloaded gelatin beads. Besides, the diffusion coefficient decreased, introducing 5% w/w of hemp hurd, from 8.91 × 10−7 to 0.77 × 10−7 cm2/s. Swelling and dissolution phenomena of gelatin beads were studied as function of pH. The swelling of gelatin beads raised as pH increased up to 2.3 g/g, 9.1 g/g and 27.33 g/g at pH 3, 7 and 12, respectively. The dissolution rate changed from 0.034 at pH 3 to 0.077 h−1 at pH 12. Release kinetics of eugenol at different pH conditions were studied. The released eugenol after 24 h is 98%, 91%, 81 and 63% w/w (pH 3), 87%, 62%, 37 and 32 wt% (pH 7) and 81%, 68%, 60 and 52 wt% (pH 12) for unloaded gelatin beads and gelatin beads with 1%, 3 and 5% of hemp hurd, respectively. The eugenol release behavior was demonstrated to be highly sensitive to the pH release medium, which allows to tune such devices as green pesticide release systems in soils with different level of acidity/basicity.

Fabrication and Release Kinetics of Liposomes Containing Leuprolide Acetate

2021 ◽  
Vol 7 (1) ◽  
pp. 35-38
Author(s):  
Sudipta Das ◽  
Arnab Samanta ◽  
Koushik Bankura ◽  
Debatri Roy ◽  
Amit Nayak
Keyword(s):  
Drug Release ◽  
Release Kinetics ◽  
In Vitro Release ◽  
Zero Order ◽  
Leuprolide Acetate ◽  
Lipid Film ◽  
In Vitro Drug Release ◽  
Liposomal Formulations ◽  
Kinetics Of

The present work is focused on the preparation and in vitro release kinetics of liposomal formulation of Leuprolide Acetate. In this work, “Thin Lipid Film Hydration Method” was used for preparation of Leuprolide Acetate loaded liposomes. Prepared liposomal formulations of Leuprolide acetate was evaluated by drug entrapment study, in-vitro drug release kinetics and stability studies. The percentage drug entrapment of Leuprolide acetate for F1 and F2 formulations were found to be 78.14 ± 0.67 and 66.70 ± 0.81% respectively. In-vitro drug release study of liposomal formulations had shown zero order release pattern. Regression co-efficient (R2) value of Zero order kinetics for F1 and F2 formulations were 0.9912 and 0.9676 respectively. After storing formulations for 1 month, stability testing was done at 40C.It was found that all batches were stable. These liposomal formulations of Leuprolide acetate can be formulated for parenteral application to treat prostate cancer and in women, to treat symptoms of endometriosis (overgrowth of uterine lining outside of the uterus) or uterine fibroids.

Sustained drug release using cobalt oxide nanowires for the preparation of polymer-free drug-eluting stents

2018 ◽  
Vol 33 (3) ◽  
pp. 352-362 ◽  
Author(s):  
Tarek M Bedair ◽  
Il Jae Min ◽  
Wooram Park ◽  
Yoon Ki Joung ◽  
Dong Keun Han
Keyword(s):  
Drug Release ◽  
Cobalt Oxide ◽  
Drug Eluting Stents ◽  
Therapeutic Drug ◽  
Burst Release ◽  
Release Behavior ◽  
Cobalt Chromium ◽  
Oxide Nanowires ◽  
Drug Eluting

Polymer-based drug-eluting stents (DESs) represented attractive application for the treatment of cardiovascular diseases; however, polymer coating has caused serious adverse responses to tissues such as chronic inflammation due to acidic by-products. Therefore, polymer-free DESs have recently emerged as promising candidates for the treatment; however, burst release of drug(s) from the surface limited its applications. In this study, we focused on delivery of therapeutic drug from polymer-free (or -less) DESs through surface modification using cobalt oxide nanowires (Co3O4 NWs) to improve and control the drug release. The results demonstrated that Co3O4 NWs could be simply fabricated on cobalt–chromium substrate by ammonia-evaporation-induced method. The Co3O4 NWs were uniformly arrayed with diameters of 50–100 nm and lengths of 10 µm. It was found that Co3O4 NWs were comparatively stable without any delamination or change of the morphology under in vitro long-term stability using circulating system. Sirolimus was used as a model drug for studying in vitro release behavior under physiological conditions. The sirolimus release behavior from flat cobalt–chromium showed an initial burst (over 90%) after one day. On the other hand, Co3O4 NWs presented a sustained sirolimus release rate for up to seven days. Similarly, the polymer-less specimens on Co3O4 NWs substrates sustained sirolimus release for a longer-period of time when compared to flat Co–Cr substrates. In summary, the current approach of using Co3O4 NWs-based substrates might have a great potential to sustain drug release for drug-eluting implants and medical devices including stents.

scholarly journals Preparation and Drug-Release Kinetics of Porous Poly(L-lactic acid)/Rifampicin Blend Particles

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Takashi Sasaki ◽  
Hiroaki Matsuura ◽  
Kazuki Tanaka
Keyword(s):  
Lactic Acid ◽  
Drug Release ◽  
Release Kinetics ◽  
Drug Carrier ◽  
Controlled Drug Release ◽  
Solution Concentration ◽  
Porous Polymer ◽  
High Porosity ◽  
Original Solution ◽  
Kinetics Of

Porous polymer spheres are promising materials as carriers for controlled drug release. As a new drug-carrier material, blend particles composed of poly(L-lactic acid) (PLLA) and rifampicin were developed using the freeze-drying technique. The blend particles exhibit high porosity with a specific surface area of 10–40 m2 g−1. Both the size and porosity of the particles depend on the concentration of the original solution and on the method of freezing. With respect to the latter, we used the drop method (pouring the original solution dropwise into liquid nitrogen) and the spray method (freezing a mist of the original solution). The release kinetics of rifampicin from the blend particles into water depends significantly on the morphology of the blend particles. The results show that the release rate can be controlled to a great extent by tuning the size and porosity of the blend particles, both of which are varied by parameters such as the solution concentration and the method of freezing.

Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants

2011 ◽  
Vol 156 (1) ◽  
pp. 37-45 ◽  
Author(s):  
Catrin Strobel ◽  
Nicole Bormann ◽  
Anke Kadow-Romacker ◽  
Gerhard Schmidmaier ◽  
Britt Wildemann
Keyword(s):  
Release Kinetics ◽  
Polymeric Coating ◽  
Sequential Release ◽  
Igf I ◽  
Kinetics Of
Sign in / Sign up

Export Citation Format

Share Document